Literature DB >> 7411661

Retroperitoneal hematoma following trauma: its clinical importance.

J G Grieco, J F Perry.   

Abstract

Records of 100 consecutive patients treated in 1973 through 1977 with post-traumatic retroperitoneal hematomas (RH) were studied. Eighty RH followed blunt injury and 20 were due to penetrating trauma. Overall mortality was 26%. The worst prognosis was associated with RH from automobile accidents and pedestrian injuries. Pelvic RH were almost uniformly associated with pelvic fracture and were the primary cause of 39% of deaths. Blunt perinephric RH required renal exploration in 47% of patients. Blunt RH in other locations were associated with major visceral or vascular injury in half the patients and were the cause of death in five. Sixty-five per cent of RH due to penetrating trauma had visceral or vascular injury requiring operative correction. Contained rupture of descending choracic aorta presented as retrogastric RH in two patients. RH from penetrating trauma should be explored routinely, since 65% are associated with visceral or vascular injury.

Entities:  

Mesh:

Year:  1980        PMID: 7411661     DOI: 10.1097/00005373-198009000-00004

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  3 in total

Review 1.  Management of traumatic retroperitoneal hematoma.

Authors:  D V Feliciano
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

2.  Blood loss and transcapillary refill in uncontrolled treated hemorrhage in dogs.

Authors:  Elias Aissar Sallum; Sueli Sinozaki; Ana Maria Calil; Raul Coimbra; Maurício Rocha E Silva; Luis Francisco Poli de Figueiredo; Dario Birolini
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

3.  Severity, Challenges, and Outcome of Retroperitoneal Hematoma in a Nigeria Tertiary Hospital.

Authors:  Arowolo Olukayode Adeolu; Adisa Adewale Oluseye; Kolawole Oladapo Adedayo; Rotimi Adedeji David; Funmilola Olanike Wuraola
Journal:  Niger J Surg       Date:  2016 Jul-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.